Alicia DeFrancesco

Alicia DeFrancesco is a senior executive at AlloVir, a biotechnology company focused on developing cell therapies for virus-associated diseases in immunocompromised patients.12 Her current role is Senior Director, Head of Commercial Strategy and Operations at AlloVir, which she has held since October 2021.13

Career Progression

Alicia's career at AlloVir has shown steady advancement:

• Current Position: Senior Director, Head of Commercial Strategy and Operations (since October 2021)
• Previous Role: Director, Chief of Staff, Office of the CEO (October 2021)
• Earlier Position: Associate Director, Commercial & New Product Development (November 2020 - October 2021)

Professional Background

Before joining AlloVir, Alicia gained valuable experience in consulting and research:

• Putnam Associates: Worked as a Consultant and Life Sciences Consultant (September 2017 - November 2020)
• Harvard University: Served as a Graduate Research Assistant and Teaching Fellow

Education

Alicia has a strong educational background in biology:

• Ph.D. in Biology: Harvard University (2017)
• Bachelor of Science in Biology: Massachusetts Institute of Technology (2008)

Research Experience

Throughout her career, Alicia has been involved in various research projects:

• Conducted research on Staphylococcus aureus biofilm formation at Harvard
• Worked as a Research and Innovation Fellow at the University of Venda
• Held positions as a Research Assistant at Tufts Medical Center and as an Intern at Institut Pasteur

Alicia DeFrancesco's diverse experience in research, consulting, and biotechnology has equipped her with a unique skill set that she now applies to her leadership role at AlloVir.1